Walleye Capital LLC Novo Cure LTD Call Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.61 - $23.34 $14,049 - $21,006
-900 Reduced 42.86%
1,200 $18,000
Q2 2024

Aug 14, 2024
SELL
$11.83 - $24.05 $13,013 - $26,455
-1,100 Reduced 34.38%
2,100 $35,000
Q1 2024

May 15, 2024
SELL
$12.42 - $17.29 $29,808 - $41,496
-2,400 Reduced 42.86%
3,200 $50,000
Q4 2023

Feb 14, 2024
BUY
$11.13 - $15.78 $14,469 - $20,514
1,300 Added 30.23%
5,600 $83,000
Q3 2023

Nov 14, 2023
BUY
$16.15 - $42.35 $64,599 - $169,400
4,000 Added 1333.33%
4,300 $69,000
Q2 2023

Aug 14, 2023
SELL
$40.29 - $82.51 $342,465 - $701,335
-8,500 Reduced 96.59%
300 $12,000
Q1 2023

May 15, 2023
BUY
$56.44 - $118.81 $440,232 - $926,718
7,800 Added 780.0%
8,800 $529,000
Q4 2022

Feb 14, 2023
SELL
$63.98 - $85.37 $268,716 - $358,554
-4,200 Reduced 80.77%
1,000 $73,000
Q3 2022

Nov 14, 2022
BUY
$67.99 - $89.57 $353,548 - $465,763
5,200 New
5,200 $395,000
Q4 2019

Feb 14, 2020
SELL
$68.3 - $93.8 $307,350 - $422,100
-4,500 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$61.86 - $97.8 $6,186 - $9,780
-100 Reduced 2.17%
4,500 $337,000
Q2 2019

Aug 14, 2019
SELL
$42.22 - $63.23 $607,968 - $910,512
-14,400 Reduced 75.79%
4,600 $291,000
Q1 2019

May 15, 2019
BUY
$31.96 - $56.12 $607,240 - $1.07 Million
19,000 New
19,000 $915,000

Others Institutions Holding NVCR

# of Institutions
263
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.16B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email